Sale!

Chlamydia Trachomatis N. Gonorrhea M. Genitalium Treponema Palidium Multiplex Detection and Differentiation RNA Detection Qualitative Test

Original price was: 3,000 د.إ.Current price is: 2,600 د.إ.

-13%

The “Chlamydia Trachomatis, N. Gonorrhea, M. Genitalium, Treponema Pallidum Multiplex Detection and Differentiation RNA Detection Qualitative Test” is a sophisticated diagnostic tool designed to identify and distinguish between the RNA of four major sexually transmitted infections (STIs): Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium, and Treponema pallidum, the bacterium responsible for syphilis. This qualitative test employs advanced RNA detection techniques to accurately diagnose the presence of these pathogens in a single sample, offering a comprehensive screening approach for individuals at risk of these infections.

Performed at DNA Labs UAE, a leading facility in genetic and molecular diagnostics, this test is priced at 2600 AED. The lab utilizes state-of-the-art technology to ensure high sensitivity and specificity, providing reliable results that are crucial for the appropriate treatment and management of these infections. Early detection through such multiplex testing is vital for preventing complications associated with these STIs and for controlling their spread within populations.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

Chlamydia trachomatis N.gonorrehea.M. genataliumTreponema palidium Multiplex Detection and Differentiation RNA Detection Qualitative Test

At DNA Labs UAE, we offer the Chlamydia trachomatis N.gonorrehea.M. genataliumTreponema palidium Multiplex Detection and Differentiation RNA Detection Qualitative Test. This test is designed to detect and differentiate between these four sexually transmitted infections (STIs): Chlamydia trachomatis, N. gonorrhoeae, M. genitalium, and Treponema pallidum.

Test Details

The Chlamydia trachomatis, N. gonorrhoeae, M. genitalium, Treponema pallidum Multiplex Detection & Differentiation (RNA Detection) Qualitative Test is a diagnostic test used to detect and differentiate between these four STIs. It is a viral test performed using real-time PCR method.

Components and Price

The test costs AED 2600.0 and requires a sample condition of urethral or vaginal swab, cell culture, cervical discharge, rectum, urethra, blood, or urine.

Report Delivery

The test report will be delivered via email within 4th working day, while phone delivery will take 36 hours.

Pre Test Information

Prior to the test, patients are required to sign a consent document and provide any clinical history related to Chlamydia trachomatis, N. gonorrhoeae, M. genitalium, and Treponema pallidum infections.

Test Procedure

This multiplex test uses RNA detection to identify and differentiate between the genetic material (RNA) of these four bacteria. It is a qualitative test, meaning it can determine the presence or absence of the bacteria in the sample, but it does not provide quantitative information about the amount of bacteria present. The sample is typically collected from the affected area, such as a swab of the genital tract or urine sample, and processed in a laboratory to extract and amplify the RNA for detection.

Importance and Limitations

The Chlamydia trachomatis, N. gonorrhoeae, M. genitalium, Treponema pallidum Multiplex Detection & Differentiation (RNA Detection) Qualitative Test is an important tool for timely diagnosis and appropriate treatment of these specific STIs. However, it is important to note that this test specifically targets these four bacteria and does not detect other STIs or infections. It is also not a screening test and is typically performed when there is a clinical suspicion or specific symptoms related to these infections.

Conclusion

The Chlamydia trachomatis, N. gonorrhoeae, M. genitalium, Treponema pallidum Multiplex Detection & Differentiation (RNA Detection) Qualitative Test offered by DNA Labs UAE is a valuable diagnostic tool for the detection and differentiation of these four STIs. It provides accurate and rapid results, allowing for timely diagnosis and appropriate treatment. If you suspect you may have any of these infections, consult with a physician and consider getting tested.

Test Name Chlamydia trachomatis N.gonorrehea.M. genataliumTreponema palidium Multiplex Detection and Differentiation RNA Detection Qualitative Test
Components
Price 2600.0 AED
Sample Condition Urethral or vaginal swab, cell culture, cervical discharge, rectum, urethra, blood, Urine.
Report Delivery 4th Working Day Email : 48 hours.On phone : 36 hours
Method Real Time PCR
Test type Viral
Doctor Physician
Test Department: Genetics
Pre Test Information Need to sign Consent document and bring any clinical history of patient forChlamydia trachomatis ,N.gonorrehea.M. genatalium,Treponema palidium Multiplex Detection & Differentiation (RNA Detection) QualitativeTest
Test Details

The Chlamydia trachomatis, N. gonorrhoeae, M. genitalium, Treponema pallidum Multiplex Detection & Differentiation (RNA Detection) Qualitative Test is a diagnostic test used to detect and differentiate between these four sexually transmitted infections (STIs).

Chlamydia trachomatis is a bacterium that causes chlamydia, a common STI that can lead to serious health complications if left untreated. N. gonorrhoeae is the bacterium responsible for gonorrhea, another common STI that can also cause severe health problems if not treated. M. genitalium is a less well-known bacterium that can cause urethritis and other genital infections. Treponema pallidum is the bacterium that causes syphilis, a potentially serious STI that can affect various organs and systems in the body.

This multiplex test uses RNA detection to identify and differentiate between the genetic material (RNA) of these four bacteria. It is a qualitative test, meaning it can determine the presence or absence of the bacteria in the sample, but it does not provide quantitative information about the amount of bacteria present.

The test is typically performed using a sample collected from the affected area, such as a swab of the genital tract or urine sample. The sample is then processed in a laboratory to extract the RNA and amplify it for detection. The test can provide accurate and rapid results, allowing for timely diagnosis and appropriate treatment of the respective infections.

It is important to note that this test specifically targets these four bacteria and does not detect other STIs or infections. Additionally, it is not a screening test and is typically performed when there is a clinical suspicion or specific symptoms related to these infections.